Search - tctmd.com

Displaying 61 - 80 of 818

Sort: Relevancy | Date

Presentation TCT 2025

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Presenter: Robert W. Yeh

October 27, 2025

Presentation TCT 2025

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2025

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Presenter: Mitchell W. Krucoff

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Conference News TCT 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Todd Neale

October 26, 2025

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Caitlin E. Cox

October 26, 2025

Presentation TCT 2025

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

Presenter: Jonathan G. Schwartz

October 26, 2025

Presentation TCT 2025

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Presenter: Raj Makkar

October 26, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE

Presenter: Robert A. Lookstein

October 26, 2025

Presentation TCT 2025

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Presenter: Yuriko Hiruma

October 26, 2025

Presentation TCT 2025

Commentary

Presenter: Jeffrey W. Moses

October 26, 2025

Presentation TCT 2025

A Randomized, Multicenter, Non-Inferiority Comparison of Intravascular Lithotripsy and Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified and Refractory Coronary Lesions - The VICTORY Trial

Presenter: Matthias Bossard

October 26, 2025

Presentation TCT 2025

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Presenter: Sheriff Dodoo

October 26, 2025

Presentation TCT 2025

Commentary

Presenter: Antonio Colombo

October 26, 2025

Presentation TCT 2025

Randomized Comparison of Intravascular Lithotripsy vs. Cutting Balloon Treatment in Calcified Coronary Artery Disease – The Short-CUT Trial

Presenter: Suzanne J. Baron

October 26, 2025

Presentation TCT 2025

Commentary

Presenter: Robert A. Byrne

October 26, 2025

Advertisement

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Commentary

A Randomized, Multicenter, Non-Inferiority Comparison of Intravascular Lithotripsy and Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified and Refractory Coronary Lesions - The VICTORY Trial

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Commentary

Randomized Comparison of Intravascular Lithotripsy vs. Cutting Balloon Treatment in Calcified Coronary Artery Disease – The Short-CUT Trial

Commentary

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content